Orexigen Therapeutics, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 30th, 2017 • Orexigen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 30th, 2017 Company Industry JurisdictionOrexigen Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: